Catalog No.
Product Name
Application
Product Information
Citations
-
Prostaglandin Receptor
Carboprost methyl is a methyl ester derivative of 15(S)-15-methyl Prostaglandin F2α, targeting prostaglandin receptors. This compound exhibits enhanced membrane permeability and, upon hydrolysis in vivo, releases the active form 15(S)-15-methyl PGF2α. It serves as a potent uterine stimulant and is utilized in research applications related to reproductive biology and obstetrics. -
Prostaglandin Receptor Antagonist
AM211 sodium is a selective and potent antagonist of the prostaglandin D2 receptor type 2 (DP2), exhibiting an IC50 of 4.9 nM for human DP2 and similar efficacy in mouse, guinea pig, and rat models with IC50s of 7.8 nM, 4.9 nM, and 10.4 nM, respectively. Its oral bioavailability makes it an important tool for studying the role of DP2 in various biological processes, including inflammation and allergic responses. AM211 sodium is suitable for research applications investigating the modulation of prostaglandin signaling pathways. -
Prostaglandin Analog
Bima SA (Bimatoprost serinol amide) is a prostaglandin analog that targets the prostaglandin receptor pathway. It exhibits significant activity in reducing intraocular pressure, making it a valuable compound for glaucoma research. This reagent can be utilized to explore therapeutic strategies for managing ocular hypertension and advancing understanding of related eye disorders. -
FP Receptor Agonist
17-Phenoxy trinor prostaglandin F2α ethyl amide is a potent agonist of the Prostaglandin F2α receptor (FP receptor). This compound is primarily investigated for its efficacy in reducing intraocular pressure, making it a valuable tool in glaucoma research. Its high activity at the FP receptor suggests potential applications in studying ocular hypertension and related therapeutic strategies. -
PGT Inhibitor
T26A is a highly selective inhibitor of the prostaglandin transporter (PGT), specifically targeting PGT-mediated influx of prostaglandin E2 (PGE2). By blocking PGT activity, T26A effectively elevates extracellular PGE2 levels while reducing intracellular PGE2 metabolites and slowing the metabolism of injected PGE2 in Rattus norvegicus. This compound is valuable for research focused on understanding PGT function in adult animal models without affecting PGE2 synthesis. -
Prostaglandin Receptor
8-iso Prostaglandin F3α is an isoprostane generated from the free-radical peroxidation of eicosapentaenoic acid (EPA). The compound primarily interacts with prostaglandin receptors, although its overall biological activity remains largely unexplored. A notable study indicates that 8-iso PGF3α is inactive in thromboxane receptor-mediated assays, such as those evaluating human platelet shape change, in contrast to its isoform 8-iso PGF2α, which exhibits an effective concentration of 1 μM. This suggests potential avenues for investigating its role in lipid peroxidation-related processes. -
Prostaglandin Receptor Antagonist
MK-7246 S enantiomer is a selective antagonist of the prostaglandin receptor CRTH2. While it exhibits reduced activity compared to its R enantiomer, it is still valuable for investigating the role of CRTH2 in various biological processes. This compound is primarily used in research applications focused on asthma, allergic responses, and other inflammation-related studies. -
PGF2α Receptor Antagonist
Ebopiprant hydrochloride is a selective antagonist of the prostaglandin F2α (PGF2α) receptor, exhibiting subnanomolar affinity with a Ki of 1 nM for the human receptor. This compound effectively inhibits PGF2α-mediated signaling pathways, making it valuable for research into conditions such as glaucoma, reproductive health, and inflammation. Its selective activity allows for the exploration of PGF2α's role in various physiological and pathological processes. -
Prostaglandin Receptor Control
Latanoprost tris(triethylsilyl) ether is a synthetic precursor designed for the production of Latanoprost, a selective agonist of the prostaglandin F2α (FP) receptor. This compound is utilized in research to explore the regulation of intraocular pressure and the physiological effects of prostaglandin receptor activation. Its application is significant in studies related to glaucoma and ocular hypertension treatments. -
prostaglandin analog
ZK118182 Isopropyl ester is a prostaglandin analog that functions as an anti-inflammatory agent. It is utilized in research to investigate pharmacological effects related to prostaglandin signaling pathways. This compound shows potential in studies focused on pain modulation and other inflammatory conditions. -
Antiulcer Agent
Enprostil is a prostaglandin E2 derivative that functions as an antiulcer agent. It effectively inhibits gastrin-stimulated gastric acid secretion and reduces pepsin secretion, making it valuable for studying gastric and duodenal ulcers. Its mechanism of action targets the protective mucus layer in the gastrointestinal tract, helping to elucidate pathways involved in ulcer formation and treatment. -
Prostaglandin E1
Prostaglandin E1 isopropyl ester is an isopropyl ester derivative of prostaglandin E1, known for its enhanced penetration properties. This compound retains the biological activities of prostaglandin E1, including vasodilation and cytoprotection, making it suitable for research in cardiovascular and gastrointestinal applications. It is an important reagent for studies investigating the pharmacological effects of prostaglandins and their therapeutic potential. -
Thromboxane Receptor Blocker
AH23848 hemicalcium salt is a potent and selective thromboxane receptor blocker. It is orally active and effectively inhibits platelet deposition, making it valuable for research on thromboxane-mediated pathways in cardiovascular studies. This compound is suitable for investigating the role of thromboxane receptors in various disease models and therapeutic contexts. -
Thromboxane Synthase Inhibitor
Ro 23-3423 is a selective thromboxane synthase inhibitor with an IC50 of 0.33 μM for human platelet microsomal thromboxane synthase. This compound elevates plasma levels of prostaglandin F (PGF) and prostaglandin E2 (PGE2) in a dose-dependent manner, while reducing mean systemic arterial pressure and systemic vascular resistance. Ro 23-3423 serves as a valuable tool in the investigation of cardiovascular dynamics and the mechanisms underlying general anesthesia. -
Prostaglandin Receptor
20-Hydroxy-PGF2α is a metabolite derived from PGF2α and acts primarily on prostaglandin receptors. This compound is known to influence various biological processes, including modulation of inflammatory responses and regulation of smooth muscle contraction. It is utilized in research exploring reproductive biology and respiratory physiology, particularly in studies involving alveolar cells and metabolic pathways linked to prostaglandins. -
EP2 Receptor Agonist
Aganepag ethanediol is an agonist of the EP2 receptor, a subtype of prostaglandin receptors involved in various physiological processes. This compound exhibits significant activity in modulating intraocular pressure, making it relevant for anti-glaucoma research. Its ability to selectively activate the EP2 receptor positions it as a valuable tool in studies aimed at exploring therapeutic interventions for glaucoma and related ocular conditions. -
TxA2 Receptor Agonist
SQ 26655 is an agonist of the TxA2 receptor, known to induce aggregation of human platelets. This compound plays a crucial role in studying platelet function and thrombus formation, making it valuable for research in cardiovascular biology. Its ability to mimic thromboxane A2 activity provides insights into various pathophysiological conditions associated with hemostasis and thrombosis. -
Prostaglandin Receptor Inhibitor
KF 13218 is a potent and selective inhibitor of thromboxane B2 (TXB2) synthase, exhibiting an IC50 value of 5.3 ± 1.3 nM. This compound effectively modulates prostaglandin receptor activity, making it valuable for research focused on inflammatory responses and cardiovascular disease pathways. Its long-lasting inhibition of TXB2 synthesis supports investigations into therapeutic strategies for conditions associated with excessive thromboxane production. -
PGF2α Analog
Fenprostalene is a potent analog of prostaglandin F2α (PGF2α) that primarily targets the prostaglandin pathway. This compound is effective in veterinary medicine for inducing corpus luteum regression and lowering blood progesterone levels in dogs. Its primary applications include the treatment of pyometra and the induction of abortion, making it a critical reagent in reproductive health studies and veterinary practices.

